Innsbruck Health Promotion Program
Launched by VASCAGE GMBH · Feb 3, 2025
Trial Information
Current as of July 07, 2025
Recruiting
Keywords
ClinConnect Summary
The Innsbruck Health Promotion Program is a research study aimed at understanding how a one-time health check and intervention can improve vascular health, which relates to the health of your blood vessels. The study will look at various factors that might affect this, such as lifestyle choices, heart health, and even hearing abilities. Researchers hope to gather information about the common risk factors for vascular issues and how they relate to overall health in the community.
To participate in this study, you need to be between the ages of 65 and 74 and live in the Innsbruck area. You'll need to provide your consent to join, and it's important to note that certain individuals, such as those with legal restrictions or impaired judgment, won't be eligible. If you choose to take part, you can expect a thorough evaluation of your vascular health and might help researchers find new ways to assess health through voice and speech samples. This study is not yet recruiting participants but aims to provide valuable insights into vascular health in older adults.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Signed informed consent of subject
- • Main area of residence in Innsbruck and Innsbruck-Land
- Exclusion Criteria:
- • People who are suspended upon a court order or upon other legal processes or are accommodated according ot the Hospitalization Act, or for whom a custodian is appointed (or appointment is inititated)
- • Persons with impaired power of judgement
- • Persons who are currently engaged in military or community service
About Vascage Gmbh
Vascage GmbH is a pioneering clinical trial sponsor dedicated to advancing vascular health through innovative research and development. With a focus on enhancing patient outcomes, the company specializes in conducting rigorous clinical trials that explore novel therapies and medical devices for vascular conditions. Vascage GmbH is committed to adhering to the highest ethical standards and regulatory requirements, ensuring the safety and efficacy of its investigational products. Through collaboration with healthcare professionals and research institutions, Vascage GmbH strives to bring transformative solutions to the vascular healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Innsbruck, , Austria
Patients applied
Trial Officials
Dr.med. Lukas Mayer-Süß, PhD
Principal Investigator
Medical University of Innsbruck
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported